BRIEF published on 11/07/2024 at 09:04, 16 days ago RHÖN-KLINIKUM AG Shows Steady Progress in Q3 2024 Revenue Growth Healthcare Sector Financial Outlook RHÖN-KLINIKUM AG Q3 2024 Results
PRESS RELEASE published on 11/07/2024 at 08:59, 16 days ago RHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed RHÖN-KLINIKUM AG reports increased revenues and profit in the first nine months of 2024. EBITDA up by 2.3%. Outlook for 2024 confirmed amidst global uncertainties Revenues EBITDA Outlook Profit RHÖN-KLINIKUM AG
BRIEF published on 08/08/2024 at 09:05, 3 months 15 days ago First Half of 2024: RHÖN-KLINIKUM AG Continues Good Business Performance – Outlook Confirmed Revenue Growth Healthcare Sector Profit Increase RHÖN-KLINIKUM AG 2024 Financial Results
PRESS RELEASE published on 08/08/2024 at 09:00, 3 months 15 days ago First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed RHÖN-KLINIKUM AG reports 6.5% revenue increase and 68.9% profit growth in first half of 2024. Outlook for 2024 remains positive amid global uncertainties Revenue Increase Healthcare Sector Outlook 2024 Profit Growth RHÖN-KLINIKUM AG
BRIEF published on 05/08/2024 at 09:04, 6 months 15 days ago RHÖN-KLINIKUM AG Reports Strong Start to 2024 with Positive First Quarter Results 2024 Outlook Healthcare Industry Economic Impact RHÖN-KLINIKUM AG Q1 Financial Results
PRESS RELEASE published on 05/08/2024 at 08:59, 6 months 15 days ago RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter RHÖN-KLINIKUM AG reports a strong start to financial year 2024 with increased revenues and profits in Q1. The outlook for 2024 confirms positive expectations despite regulatory challenges Revenues Financial Year 2024 Outlook RHÖN-KLINIKUM AG Profits
BRIEF published on 03/28/2024 at 09:05, 7 months 26 days ago RHÖN-KLINIKUM AG Announces Positive Financial Results for 2023 Financial Results 2023 Performance Sustainability Healthcare RHÖN-KLINIKUM AG
PRESS RELEASE published on 03/28/2024 at 09:00, 7 months 26 days ago RHÖN-KLINIKUM AG looks back on successful financial year 2023 RHÖN-KLINIKUM AG reports successful financial year 2023 with increased revenues and profits. Strategic focus on core activities, outpatient care, and sustainability. Outlook for 2024 outlined Revenues Sustainability Financial Year 2023 RHÖN-KLINIKUM AG Profits
PRESS RELEASE published on 11/09/2023 at 09:00, 1 year ago RHÖN-KLINIKUM AG increases consolidated profit and revenues
PRESS RELEASE published on 08/10/2023 at 09:03, 1 year 3 months ago RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed
Published on 11/22/2024 at 23:55, 9 hours 25 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 50 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 15 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 50 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 6 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 27 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 25 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 20 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
